Search by Drug Name or NDC

    NDC 25021-0177-50 Piperacillin, Tazobactam 4; .5 g/20mL; g/20mL Details

    Piperacillin, Tazobactam 4; .5 g/20mL; g/20mL

    Piperacillin, Tazobactam is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is PIPERACILLIN SODIUM; TAZOBACTAM SODIUM.

    Product Information

    NDC 25021-0177
    Product ID 25021-177_da5fb916-ca41-4931-b785-80db9876dffd
    Associated GPIs 01990002702140
    GCN Sequence Number 021187
    GCN Sequence Number Description piperacillin sodium/tazobactam VIAL 4.5 G INTRAVEN
    HIC3 W1A
    HIC3 Description PENICILLIN ANTIBIOTICS
    GCN 53282
    HICL Sequence Number 008738
    HICL Sequence Number Description PIPERACILLIN SODIUM/TAZOBACTAM SODIUM
    Brand/Generic Generic
    Proprietary Name Piperacillin, Tazobactam
    Proprietary Name Suffix n/a
    Non-Proprietary Name Piperacillin Sodium, Tazobactam Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 4; .5
    Active Ingredient Units g/20mL; g/20mL
    Substance Name PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
    Labeler Name Sagent Pharmaceuticals
    Pharmaceutical Class Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208674
    Listing Certified Through 2024-12-31

    Package

    NDC 25021-0177-50 (25021017750)

    NDC Package Code 25021-177-50
    Billing NDC 25021017750
    Package 10 VIAL in 1 CARTON (25021-177-50) / 20 mL in 1 VIAL
    Marketing Start Date 2021-10-15
    NDC Exclude Flag N
    Pricing Information N/A